Annals of Oncology

News:

Heine H. Hansen

Maurizio Tonato - ESMO President 1999–2001
Ann Oncol 11: 377.
[PDF] [Request Permissions]

National plan against cancer in France
Ann Oncol 11: 378.
[PDF] [Request Permissions]

"Allègre, resign!" demand demonstrators
Ann Oncol 11: 378.
[PDF] [Request Permissions]

Lancet against overoptimism about cancer
Ann Oncol 11: 378-379.
[PDF] [Request Permissions]

Does the French government forget public hospitals?
Ann Oncol 11: 379.
[PDF] [Request Permissions]

Republican presidential candidates capitalize on alternative medicine
Ann Oncol 11: 379.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 11: 379-382.
[PDF] [Request Permissions]

Book reviews:

G. Salles

Book review
Ann Oncol 11: 382.
[PDF] [Request Permissions]

Editorial:

S. A. Grumett and P. B. Snow

Artificial neural networks: A new model for assessing prognostic factors
Ann Oncol 11: 383-384.
[PDF] [Request Permissions]

Review:

B. Van Triest, H. M. Pinedo, G. Giaccone, and G. J. Peters

Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylate synthase inhibitors
Ann Oncol 11: 385-391.
[Abstract] [PDF] [Request Permissions]

Original articles:

J.-M. Ferrero, A. Ramaioli, J.-L. Formento, M. Francoual, M.-C. Etienne, I. Peyrottes, F. Ettore, P. Leblanc-Talent, M. Namer, and G. Milano

p53 determination alongside classical prognostic factors in node-negative breast cancer: An evaluation at more than 10-year follow-up
Ann Oncol 11: 393-397.
[Abstract] [PDF] [Request Permissions]

A. J. Grillo-López, B. D. Cheson, S. J. Horning, B. A. Peterson, W. D. Carter, C. L. Varns, D. L. Klippenstein, and C. D. Shen

Response criteria for NHL: Importance of ‘normal’ lymph node size and correlations with response rates
Ann Oncol 11: 399-408.
[Abstract] [PDF] [Request Permissions]

T. J. Postma, J. J. Heimans, S. A. Luykx, C. J. van Groeningen, L. F. M. Beenen, O. S. Hoekstra, M. J. B. Taphoorn, B. A. Zonnenberg, M. Klein, and J. B. Vermorken

A phase II study of paclitaxel in chemonaïve patients with recurrent high-grade glioma
Ann Oncol 11: 409-413.
[Abstract] [PDF] [Request Permissions]

R. L. Schilsky, R. Bukowski, H. Burris, III, H. Hochster, M. O'Rourke, J. G. Wall, S. Mani, T. Bonny, J. Levin, and J. Hohneker

A multicenter phase II study of a five-day regimen of oral 5-fluorouracil plus eniluracil with or without leucovorin in patients with metastatic colorectal cancer
Ann Oncol 11: 415-420.
[Abstract] [PDF] [Request Permissions]

D. Rischin, M. Boyer, J. Smith, M. Millward, M. Michael, J. Bishop, J. Zalcberg, J. Davison, E. Emmett, and B. McClure

A phase I trial of docetaxel and gemcitabine in patients with advanced cancer
Ann Oncol 11: 421-426.
[Abstract] [PDF] [Request Permissions]

M. P. Decatris, P. M. Wilkinson, R. S. Welch, M. Metzner, G. R. Morgenstern, and M. Dougall

High-dose chemotherapy and autologous haematopoietic support in poor risk non-seminomatous germ-cell tumours: An effective first-line therapy with minimal toxicity
Ann Oncol 11: 427-434.
[Abstract] [PDF] [Request Permissions]

C. Manegold, U. Gatzemeier, J. von Pawel, R. Pirker, R. Malayeri, J. Blatter, and K. Krejcy

Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, Pemetrexed disodium, ALIMTA^TM and cisplatin: A multicenter phase II trial
Ann Oncol 11: 435-440.
[Abstract] [PDF] [Request Permissions]

J.M. Hernández, M. C. del Cañizo, A. Cuneo, J. L. García, N. C. Gutiérrez, M. González, G. Castoldi, and J. F. San Miguel

Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia
Ann Oncol 11: 441-444.
[Abstract] [PDF] [Request Permissions]

K. Kubota, T. Tamura, M. Fukuoka, K. Furuse, H. Ikegami, Y. Ariyoshi, Y. Kurita, and N. Saijo

Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: Long-term follow-up results. Japan Clinical Oncology Group Protocol 8902
Ann Oncol 11: 445-450.
[Abstract] [PDF] [Request Permissions]

M. Tischkowitz, D. Wheeler, E. France, C. Chapman, A. Lucassen, J. Sampson, P. Harper, M. Krawczak, and J. Gray

A comparison of methods currently used in clinical practice to estimate familial breast cancer risks
Ann Oncol 11: 451-454.
[Abstract] [PDF] [Request Permissions]

S. Pignata, P. Frezza, S. Tramontana, F. Perrone, R. Tambaro, G. Casella, E. Ferrari, F. Iodice, R. De Vivo, P. Ricchi, F. Tramontana, and G. Silvestro

Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri
Ann Oncol 11: 455-459.
[Abstract] [PDF] [Request Permissions]

P. Comella, F. De Vita, L. De Lucia, R. Casaretti, A. Avallone, M. Orditura, F. Rivellini, S. Palmeri, G. Catalano, G. Comella, and Southern Italy Cooperative Oncology Group

Oxaliplatin and raltitrexed combined with leucovorin-modulated 5-fluorouracil i.v. bolus every two weeks: A dose finding study in advanced previously treated colorectal carcinoma
Ann Oncol 11: 461-468.
[Abstract] [PDF] [Request Permissions]

P. N. Butow, A. S. Coates, and S. M. Dunn

Psychosocial predictors of survival: Metastatic breast cancer
Ann Oncol 11: 469-474.
[Abstract] [PDF] [Request Permissions]

A. Y. Nerurkar, P. Vijayan, V. Srinivas, C. S. Soman, K. A. Dinshaw, S. H. Advani, I. Magrath, K. Bhatia, and K. N. Naresh

Discrepancies in Epstein—Barr virus association at presentation and relapse of classical Hodgkin's disease: Impact on pathogenesis
Ann Oncol 11: 475-478.
[Abstract] [PDF] [Request Permissions]

D. Santini, G. Tonini, A. Abbate, S. Di Cosimo, G. Gravante, B. Vincenzi, C. Campisi, G. Patti, and G. Di Sciascio

Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity
Ann Oncol 11: 479-481.
[Abstract] [PDF] [Request Permissions]

Clinical case:

M. Iqbal, E. Marshall, and J.A. Green

Ten-year survival in advanced malignant melanoma following treatment with interferon and vindesine
Ann Oncol 11: 483-485.
[Abstract] [PDF] [Request Permissions]

P. A. Ascierto, G. Palmieri, M. Strazzullo, A. Daponte, G. Botti, S.M.R. Satriano, M.L. Motti, N. Mozzillo, G. Castello, and The Melanoma Cooperative Group

Low doses interferon- in the treatment of high-risk cutaneous melanoma
Ann Oncol 11: 487-490.
[PDF] [Request Permissions]

V.D. Corleto, S. Angeletti, O. Schillaci, M. Marignani, M. Caratozzolo, F. Panzuto, B. Annibale, and G. Delle Fave

Long-term octreotide treatment of metastatic carcinoid tumor
Ann Oncol 11: 491-493.
[Abstract] [PDF] [Request Permissions]

Short report:

R. Valenza, V. Leonardi, V. Gebbia, and B. Agostara

Gemcitabine and vinorelbine in pretreated advanced breast cancer: A pilot study
Ann Oncol 11: 495-496.
[Abstract] [PDF] [Request Permissions]

Letter to the editor:

C. Garufi, S. Vaglio, S. Brienza, L. Conti, R. M. D'Attino, G. Girelli, and E. Terzoli

Immunohemolytic anemia following oxaliplatin administration
Ann Oncol 11: 497.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.